drugset / Trial / NCT03777514

Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient

NCT03777514 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to compare two accepted treatments for iron deficiency anemia (oral ferrous sulfate and intravenous ferumoxytol) for efficacy and speed of response in the treatment of iron deficiency anemia (IDA) in the post-operative bariatric surgical patient. In this study, 104 bariatric surgical post-operative patients will be randomly assigned 52 each to oral or 52 to a single dose IV iron treatment using double-blind procedures.

Timeline

Start
2019-08
Primary completion
2021-10
Completion
2022-09

Outcome

Outcome not reported

Stopped: “Study wasn't started.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 325 mg Oral
Comparator Ferumoxytol Diagnostic / imaging agent 510 mg Intravenous